FAM3D
gene geneOn this page
Also known as EF7OIT1
Summary
FAM3D (FAM3 metabolism regulating signaling molecule D, HGNC:18665) is a protein-coding gene on chromosome 3p14.2, encoding Protein FAM3D (Q96BQ1).
Predicted to enable cytokine activity. Involved in negative regulation of insulin secretion. Predicted to be located in extracellular region. Predicted to be active in extracellular space.
Source: NCBI Gene 131177 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 45 total
- MANE Select transcript:
NM_138805
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18665 |
| Approved symbol | FAM3D |
| Name | FAM3 metabolism regulating signaling molecule D |
| Location | 3p14.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | EF7, OIT1 |
| Ensembl gene | ENSG00000198643 |
| Ensembl biotype | protein_coding |
| OMIM | 608619 |
| Entrez | 131177 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 26 protein_coding, 1 nonsense_mediated_decay
ENST00000358781, ENST00000482623, ENST00000483787, ENST00000489857, ENST00000498347, ENST00000876434, ENST00000876435, ENST00000876436, ENST00000876437, ENST00000876438, ENST00000876439, ENST00000876440, ENST00000876441, ENST00000876442, ENST00000876443, ENST00000876444, ENST00000876445, ENST00000876446, ENST00000876447, ENST00000951607, ENST00000951608, ENST00000951609, ENST00000951610, ENST00000951611, ENST00000951612, ENST00000951613, ENST00000951614
RefSeq mRNA: 1 — MANE Select: NM_138805
NM_138805
CCDS: CCDS2893
Canonical transcript exons
ENST00000358781 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001009838 | 58636294 | 58636420 |
| ENSE00001009839 | 58637141 | 58637225 |
| ENSE00001077342 | 58653674 | 58653781 |
| ENSE00001077343 | 58633946 | 58634368 |
| ENSE00001077347 | 58666576 | 58666774 |
| ENSE00001077349 | 58649315 | 58649338 |
| ENSE00001398795 | 58655551 | 58655601 |
| ENSE00003469252 | 58645509 | 58645626 |
| ENSE00003469580 | 58640127 | 58640177 |
| ENSE00003663772 | 58643662 | 58643720 |
Expression profiles
Bgee: expression breadth ubiquitous, 172 present calls, max score 99.58.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.4030 / max 660.4470, expressed in 86 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 42743 | 0.7427 | 50 |
| 42747 | 0.5881 | 44 |
| 42748 | 0.4507 | 36 |
| 42742 | 0.4068 | 42 |
| 42744 | 0.0803 | 13 |
| 42746 | 0.0658 | 22 |
| 42745 | 0.0558 | 11 |
| 42741 | 0.0127 | 7 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 99.58 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 99.43 | gold quality |
| rectum | UBERON:0001052 | 99.39 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 98.92 | gold quality |
| colonic mucosa | UBERON:0000317 | 98.84 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 98.74 | gold quality |
| ileal mucosa | UBERON:0000331 | 98.68 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.60 | gold quality |
| parotid gland | UBERON:0001831 | 98.55 | gold quality |
| trachea | UBERON:0003126 | 98.38 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 98.32 | gold quality |
| esophagus mucosa | UBERON:0002469 | 97.60 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 97.41 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 97.31 | gold quality |
| oral cavity | UBERON:0000167 | 96.90 | gold quality |
| minor salivary gland | UBERON:0001830 | 96.90 | gold quality |
| gall bladder | UBERON:0002110 | 96.77 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 96.69 | gold quality |
| mouth mucosa | UBERON:0003729 | 95.74 | gold quality |
| pylorus | UBERON:0001166 | 94.80 | gold quality |
| pancreatic ductal cell | CL:0002079 | 93.92 | silver quality |
| duodenum | UBERON:0002114 | 93.72 | gold quality |
| buccal mucosa cell | CL:0002336 | 93.34 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 92.82 | gold quality |
| tonsil | UBERON:0002372 | 92.68 | gold quality |
| superior surface of tongue | UBERON:0007371 | 92.61 | gold quality |
| tongue | UBERON:0001723 | 92.58 | gold quality |
| amniotic fluid | UBERON:0000173 | 92.55 | gold quality |
| bronchus | UBERON:0002185 | 92.49 | gold quality |
| bronchial epithelial cell | CL:0002328 | 92.25 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 6.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8410 | yes | 1086.81 |
| E-CURD-114 | yes | 710.38 |
| E-CURD-88 | yes | 404.23 |
| E-GEOD-125970 | yes | 44.70 |
| E-HCAD-1 | yes | 12.04 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting FAM3D, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-3187-5P | 98.36 | 65.74 | 1776 |
| HSA-MIR-634 | 97.74 | 67.11 | 818 |
| HSA-MIR-1285-3P | 97.72 | 67.02 | 1932 |
| HSA-MIR-5189-5P | 97.72 | 66.96 | 1814 |
| HSA-MIR-3620-5P | 97.42 | 63.95 | 792 |
| HSA-MIR-10400-3P | 97.29 | 64.66 | 597 |
| HSA-MIR-4674 | 97.29 | 64.62 | 597 |
| HSA-MIR-612 | 97.26 | 65.95 | 1597 |
| HSA-MIR-6860 | 97.21 | 66.31 | 1656 |
| HSA-MIR-1587 | 96.95 | 64.03 | 932 |
| HSA-MIR-345-5P | 96.40 | 66.43 | 663 |
Literature-anchored findings (GeneRIF, showing 7)
- A cytokine-like protein found in placenta (PMID:12160727)
- Statistical analysis indicated that six genes, NFATC2, SCP2, CACNA1C, TCRA, POLE, and FAM3D, were associated with narcolepsy. (PMID:20677014)
- Fam3D is a gut-derived protein that is expressed and secreted in a nutritional status-dependent manner (PMID:22226334)
- FAM3D plays a role in gastrointestinal homeostasis and inflammation through its receptors FPR1 and FPR2. (PMID:26966188)
- Targeting cytokine-like protein FAM3D lowers blood pressure in hypertension. (PMID:37301198)
- Hepatocyte-secreted FAM3D ameliorates hepatic steatosis by activating FPR1-hnRNP U-GR-SCAD pathway to enhance lipid oxidation. (PMID:37454871)
- DNA methylation-driven gene FAM3D promotes colorectal cancer growth via the ATF4-SESN2-mTORC1 pathway. (PMID:39388305)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam3d | ENSMUSG00000021749 |
| rattus_norvegicus | Fam3d | ENSRNOG00000007320 |
| caenorhabditis_elegans | WBGENE00019786 |
Paralogs (3): FAM3A (ENSG00000071889), FAM3B (ENSG00000183844), FAM3C (ENSG00000196937)
Protein
Protein identifiers
Protein FAM3D — Q96BQ1 (reviewed: Q96BQ1)
All UniProt accessions (6): A0A0A8K9B4, C9IZW7, C9J5Z5, C9JB68, Q96BQ1, F8WCI4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Tissue specificity. Abundantly expressed in placenta and weakly expressed in small intestine.
Similarity. Belongs to the FAM3 family.
RefSeq proteins (1): NP_620160* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039220 | FAM3 | Family |
| IPR039475 | ILEI_FAM3C | Domain |
| IPR039477 | ILEI/PANDER_dom | Domain |
Pfam: PF15711
UniProt features (8 total): disulfide bond 2, sequence variant 2, signal peptide 1, chain 1, domain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96BQ1-F1 | 90.82 | 0.77 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 55–83, 61–218
Glycosylation sites (1): 107
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 121 (showing top):
GOBP_MYELOID_CELL_HOMEOSTASIS, GOBP_MYELOID_LEUKOCYTE_MIGRATION, GOBP_INSULIN_SECRETION, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION, GOBP_HORMONE_TRANSPORT, GOBP_ARTERY_DEVELOPMENT, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_CELL_CELL_SIGNALING, GOBP_AORTA_DEVELOPMENT, GOBP_REGULATION_OF_PROTEIN_SECRETION, GOBP_LEUKOCYTE_MIGRATION, GOBP_NEGATIVE_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN
GO Biological Process (6): neutrophil homeostasis (GO:0001780), positive regulation of macrophage antigen processing and presentation (GO:0002618), aorta development (GO:0035904), negative regulation of insulin secretion (GO:0046676), neutrophil migration (GO:1990266), signal transduction (GO:0007165)
GO Molecular Function (3): cytokine activity (GO:0005125), carbohydrate binding (GO:0030246), protein binding (GO:0005515)
GO Cellular Component (3): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| cellular anatomical structure | 2 |
| leukocyte homeostasis | 1 |
| myeloid cell homeostasis | 1 |
| macrophage antigen processing and presentation | 1 |
| positive regulation of antigen processing and presentation | 1 |
| regulation of macrophage antigen processing and presentation | 1 |
| artery development | 1 |
| insulin secretion | 1 |
| negative regulation of protein secretion | 1 |
| regulation of insulin secretion | 1 |
| negative regulation of peptide hormone secretion | 1 |
| granulocyte migration | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| receptor ligand activity | 1 |
Protein interactions and networks
STRING
388 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM3D | FPR2 | P25090 | 572 |
| FAM3D | FPR1 | P21462 | 559 |
| FAM3D | GUF1 | Q8N442 | 473 |
| FAM3D | BPIFA1 | Q9NP55 | 412 |
| FAM3D | RAB11FIP1 | Q6WKZ4 | 402 |
| FAM3D | LCE5A | Q5TCM9 | 368 |
| FAM3D | CRNN | Q9UBG3 | 333 |
| FAM3D | TMPRSS11B | Q86T26 | 331 |
| FAM3D | RARRES1 | P49788 | 326 |
| FAM3D | PRR15L | Q9BU68 | 324 |
| FAM3D | OR4C46 | A6NHA9 | 323 |
| FAM3D | ZNF530 | Q6P9A1 | 323 |
| FAM3D | FAM107A | O95990 | 319 |
| FAM3D | DENND10 | Q8TCE6 | 285 |
| FAM3D | TLCD2 | A6NGC4 | 275 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM3D | PKD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM3D | HSPA8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FAM3D | CNN1 | psi-mi:“MI:0914”(association) | 0.350 |
| FAM3D | PEX5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (11): PKD2 (Affinity Capture-MS), PKD2 (Affinity Capture-MS), FAM3D (Proximity Label-MS), PKD2 (Affinity Capture-MS), CNN1 (Affinity Capture-MS), GLT8D1 (Affinity Capture-MS), DSCC1 (Affinity Capture-MS), PEX5 (Affinity Capture-MS), SPECC1L (Affinity Capture-MS), FAM3D (Co-fractionation), FAM3D (Co-fractionation)
ESM2 similar proteins: A0JNU3, A1L1F1, A2AIL4, A4IHH4, A4QP75, B3MGZ0, B4GGT6, F6ZFR0, O00746, O08776, O55137, O55171, O88202, O88267, P36776, P49753, P87355, Q28CM7, Q32LB9, Q330K2, Q3B8B2, Q3T056, Q4R816, Q4VK78, Q566Y1, Q58DL1, Q59HJ6, Q5EBA1, Q5RJV0, Q6DFN1, Q80YD1, Q810S1, Q86U10, Q8BWN8, Q8CGK3, Q8HY87, Q8NC60, Q924S5, Q96BQ1, Q99KK9
Diamond homologs: A5PKI3, B0BLS9, P58499, P97805, P98173, Q5R5C3, Q6GQC1, Q7ZYY4, Q810F4, Q8BI06, Q8WUJ3, Q91VU0, Q92520, Q96BQ1, Q9D309, Q9D8T0, Q5EAB6, Q5RCB9, Q5XIN7, Q8WZA1, Q91X88, P26572, P27115, P27808, Q09325, Q11068, Q9XGM8, A3KPQ7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1887 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:58634369:C:CC | acceptor_gain | 1.0000 |
| 3:58636312:ACC:A | donor_gain | 1.0000 |
| 3:58636313:CCC:C | donor_gain | 1.0000 |
| 3:58636417:CATT:C | acceptor_gain | 1.0000 |
| 3:58636419:TT:T | acceptor_gain | 1.0000 |
| 3:58636421:C:CC | acceptor_gain | 1.0000 |
| 3:58637133:CTACT:C | donor_loss | 1.0000 |
| 3:58637134:TACTT:T | donor_loss | 1.0000 |
| 3:58637135:ACTTA:A | donor_loss | 1.0000 |
| 3:58637137:TTA:T | donor_loss | 1.0000 |
| 3:58637138:TA:T | donor_loss | 1.0000 |
| 3:58637139:A:AC | donor_gain | 1.0000 |
| 3:58637140:C:CG | donor_gain | 1.0000 |
| 3:58637223:CAT:C | acceptor_gain | 1.0000 |
| 3:58637226:C:CC | acceptor_gain | 1.0000 |
| 3:58645502:TAC:T | donor_loss | 1.0000 |
| 3:58645503:ACT:A | donor_loss | 1.0000 |
| 3:58645504:CT:C | donor_loss | 1.0000 |
| 3:58645505:TTAC:T | donor_loss | 1.0000 |
| 3:58645506:T:TG | donor_loss | 1.0000 |
| 3:58645507:A:AC | donor_gain | 1.0000 |
| 3:58645507:ACATG:A | donor_gain | 1.0000 |
| 3:58645508:C:CC | donor_gain | 1.0000 |
| 3:58645508:CATG:C | donor_gain | 1.0000 |
| 3:58645508:CATGC:C | donor_gain | 1.0000 |
| 3:58645625:CT:C | acceptor_gain | 1.0000 |
| 3:58645627:C:CC | acceptor_gain | 1.0000 |
| 3:58636345:G:C | donor_gain | 0.9900 |
| 3:58636416:TCATT:T | acceptor_gain | 0.9900 |
| 3:58636417:CATTC:C | acceptor_gain | 0.9900 |
AlphaMissense
1488 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:58636344:A:G | W179R | 0.999 |
| 3:58636344:A:T | W179R | 0.999 |
| 3:58634327:C:A | W209C | 0.998 |
| 3:58634327:C:G | W209C | 0.998 |
| 3:58634329:A:G | W209R | 0.998 |
| 3:58634329:A:T | W209R | 0.998 |
| 3:58636342:C:A | W179C | 0.998 |
| 3:58636342:C:G | W179C | 0.998 |
| 3:58636352:C:G | R176P | 0.998 |
| 3:58636378:A:C | S167R | 0.998 |
| 3:58636378:A:T | S167R | 0.998 |
| 3:58636380:T:G | S167R | 0.998 |
| 3:58645556:A:C | S72R | 0.998 |
| 3:58645556:A:T | S72R | 0.998 |
| 3:58645558:T:G | S72R | 0.998 |
| 3:58636349:T:A | D177V | 0.997 |
| 3:58636354:G:C | F175L | 0.997 |
| 3:58636354:G:T | F175L | 0.997 |
| 3:58636356:A:G | F175L | 0.997 |
| 3:58637156:T:A | D148V | 0.997 |
| 3:58637157:C:G | D148H | 0.997 |
| 3:58643678:G:C | N102K | 0.997 |
| 3:58643678:G:T | N102K | 0.997 |
| 3:58645533:G:T | P80H | 0.997 |
| 3:58645554:C:T | G73E | 0.997 |
| 3:58645555:C:A | G73W | 0.997 |
| 3:58637165:G:T | A145D | 0.996 |
| 3:58643682:A:G | L101P | 0.996 |
| 3:58643685:C:A | G100V | 0.996 |
| 3:58643686:C:G | G100R | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000031450 (3:58651023 T>G), RS1000034674 (3:58642601 C>A), RS1000097837 (3:58634774 G>A), RS1000284070 (3:58656886 G>A), RS1000343914 (3:58663077 T>G), RS1000438816 (3:58662922 A>G), RS1000496654 (3:58668183 T>C), RS1000520383 (3:58665792 A>C), RS1000634524 (3:58657132 C>T), RS1000703721 (3:58635937 C>A), RS1000803360 (3:58641659 C>T), RS1000834799 (3:58641468 C>G,T), RS1000953044 (3:58667946 G>A), RS1001020860 (3:58659930 T>C), RS1001034628 (3:58652576 C>A,G,T)
Disease associations
OMIM: gene MIM:608619 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003542_43 | Night sleep phenotypes | 4.000000e-06 |
| GCST006585_1319 | Blood protein levels | 3.000000e-18 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, affects methylation | 2 |
| terbufos | increases methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Arbutin | decreases expression | 1 |
| Fonofos | increases methylation | 1 |
| Methapyrilene | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.